分析测试百科网 > 行业资讯 > 焦点事件

2014中国（南京）国际生物医药产业博览会部分海外企业预览

2014.4.11

　　Regen Lab

　　Application of Autologous Platelet Rich Plasma has been evaluated in various medical disciplines including orthopaedics, sports medicine, wound healing, neurosurgery, dentistry, ophthalmology as well as cosmetic, plastic, maxillofacial and cardiothoracic surgery.

　　The technology is processing the patient´s own blood, fat or bone marrow to use the concentrated cells.

　　Autologous Platelet Rich Plasma also contains fibrin, fibronectin and vitronectin that act as cell adhesion molecules for osteoconduction and as a matrix for bone, connective tissue and epithelial migration 4.

　　The Regen Extracell BMC technology and its products aim is to dramatically enhance tissue regeneration toward a quicker and more successful patient’s recovery. At the edge of the latest developments of the cellular therapy research, the Regen Extracell contribution in the world of orthopaedics wishes to be safe and realistic

　　Swissnex - China

　　Swissnex is a network with nodes in the world's most innovative hubs, where the future is being shaped. We take an active role in strengthening Switzerland's leadership as a world-class location for science, education and innovation. Our core value lies in our ability to:

　　Strengthen Switzerland's profile as a nation of leading-edge research, quality, innovation and openness

　　Connect scientists, researchers, entrepreneurs, policy-makers and thought leaders with inspiring peers and new ideas on either side of the globe

　　Facilitate academic programs, global innovation strategies, and knowledge exchange

　　Create and present transdisciplinary projects in imaginative ways

　　Network with relevant contacts at universities, research institutions, and companies to maintain a powerful web of worldwide knowledge

　　Support internationalization efforts of Swiss academic institutions

　　Share innovative achievements and emerging trends in the host country and in Switzerland

　　Inform on developments in science, technology, education and innovation process

　　Participate in our communities and interact with Swiss and local partners to bring added value

　　TRB Chemedica

　　The company markets a range of ethical pharmaceuticals and medical devices in more than 40 countries. They have a subsidiary in Hong Kong and are committed to growth in the international arena

　　Development of its own products in niche therapeutic areas (rheumatology, ophthalmology and neurology):

　　- Diacerein: the first and only oral IL-1 inhibitor for use in the treatment of osteoarthritis,

　　- Hyaluronic Acid: for intra-articular administration in the treatment of osteoarthritis,

　　- Vislube and Vismed lines: for topical ocular use as lubricants in the treatment of sensations of ocular dryness,

　　- Visiol: for intra-ocular use during ocular surgery.

　　- Drug for the treatment of Parkinson disease.

　　Springer and Adis products

　　Springer is a leading global publisher and publishes around 2000 journals and more than 4000 new books yearly. The Adis journals and newsletters and the three Adis databases are part of the Springer collection: Adis R&D Insight, Adis Clinical Trials Insight and Pharmacovigilance Insight.

　　With Springer for Research and Development Content Solutions, companies of all sizes can purchase and deliver Springer products tailored for their employee’s specific needs. Customizable purchase models and flexible pricing enable companies to select only the content that they require.

　　For instant access, reference materials, proven fixes and best practices, trusted, targeted information: rd.springer.com

　　点击这里进行在线参观预登记!

　　联系方式

　　电话：025-83418350

　　传真：025-83518322-818

　　邮箱：info@biotechchina-nj.com

　　地址：南京市长江路188号德基大厦12楼B座

生物医药

喜欢作者我要约稿